| Literature DB >> 30210824 |
Katharina Martini1, Thomas Frauenfelder1.
Abstract
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. One of the main findings is pulmonary emphysema in association with chronic bronchitis. Clinical signs, pulmonary function tests and imaging are the current used methods to diagnose and stage emphysema. Lung volume reduction (LVR) and endoscopic lung volume reduction (ELVR) are the current therapeutic options beside lung transplantation in cases of severe emphysema. Nowadays imaging is one of the key factors for the success of these therapies. Especially quantitative computed tomography (CT) with its increasing possibilities has become a viable tool, providing detailed information about distribution and heterogeneity of emphysema. Other imaging techniques like dual-energy CT (DECT) and functional magnetic resonance (MR) have shown to add functional information. These structural and functional information support thoracic surgeons and interventional pulmonologists in selecting patients and optimizing LVR procedures but also enables the development of new endobronchial therapies. Imaging will further improve the individual outcome by supporting the choice of optimal therapy.Entities:
Keywords: Lung volume reduction (LVR); computed tomography (CT); endobronchial procedure; preinterventional imaging
Year: 2018 PMID: 30210824 PMCID: PMC6129802 DOI: 10.21037/jtd.2018.05.117
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895